0000914317-13-000735.txt : 20130524 0000914317-13-000735.hdr.sgml : 20130524 20130524111652 ACCESSION NUMBER: 0000914317-13-000735 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130523 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Other Events FILED AS OF DATE: 20130524 DATE AS OF CHANGE: 20130524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CONMED CORP CENTRAL INDEX KEY: 0000816956 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 160977505 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-16093 FILM NUMBER: 13870679 BUSINESS ADDRESS: STREET 1: 525 FRENCH ROAD CITY: UTICA STATE: NY ZIP: 13502 BUSINESS PHONE: 315-624-3215 MAIL ADDRESS: STREET 1: 525 FRENCH ROAD CITY: UTICA STATE: NY ZIP: 13502 8-K 1 form8k-130874_cnmd.htm 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15 (d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Date of Report (Date of earliest event reported): May 23, 2013

 

 

CONMED CORPORATION

(Exact name of registrant as specified in its charter)

 

 

New York 0-16093 16-0977505
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification No.)

 

 

 

525 French Road

Utica, New York 13502

(Address of principal executive offices, including zip code)

 

 

 

(315) 797-8375

(Registrant's telephone number, including area code)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

The annual meeting of shareholders of CONMED Corporation was held on May 23, 2013 (the “Annual Meeting”). Holders of Common Stock were entitled to elect seven directors. On all matters which came before the Annual Meeting, holders of Common Stock were entitled to one vote for each share held. Proxies for 26,978,556 of the 27,856,208 shares of Common Stock entitled to vote were received in connection with the Annual Meeting.

 

The following table sets forth the names of the seven persons elected at the Annual Meeting to serve as directors until the first annual meeting of shareholders following the end of the Company’s fiscal year ending December 31, 2013 and the number of votes cast for, against or withheld with respect to each person.

 

Election of Directors

 

Director Votes Received Votes Withheld Broker Non-Votes
       
Eugene R. Corasanti 23,835,363 1,828,956 1,314,237
Joseph J. Corasanti 25,565,962      98,357 1,314,237
Bruce F. Daniels 22,060,161 3,604,158 1,314,237
Jo Ann Golden 23,339,115 2,325,204 1,314,237
Stephen M. Mandia 25,621,959      42,360 1,314,237
Stuart J. Schwartz 22,046,691 3,617,628 1,314,237
Mark E. Tryniski 25,628,799      35,520 1,314,237

 

 

Management Proposals

 

  For Against Abstain Broker
 Non-Votes
Ratification of the appointment of PricewaterhouseCoopers LLP as independent accountants for the Company for the fiscal year ending December 31, 2013 26,846,145 122,966   9,445 —
         
Approve advisory vote on executive compensation 24,915,578  520,376 228,364 1,314,238

 

Item 8.01 Other Events

 

On May 24, 2013, CONMED Corporation announced it will be paying a quarterly cash dividend of $0.15 per share on July 8, 2013 to all shareholders of record as of June 17, 2013.

 
 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  CONMED CORPORATION
             (Registrant)
     
     
  By: /s/ Robert D. Shallish, Jr.
    Executive VP, Finance and
    Chief Financial Officer

 

Date: May 23, 2013